Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (30)
COVID-19 (12)
Type
Type
Guidance (1194)
NICE advice (215)
Quality standard (130)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (20)
Clinical guidelines (181)
COVID-19 rapid guidelines (3)
Diagnostics guidance (37)
Health technology evaluations (18)
Highly specialised technologies guidance (27)
Interventional procedures guidance (220)
Medical technologies guidance (60)
Medicines practice guidelines (2)
NICE guidelines (244)
Public health guidelines (26)
Social care guidelines (40)
Technology appraisal guidance (588)
Advice programme
Advice programme
Evidence summaries (20)
Medtech innovation briefings (195)
Apply filters
Showing 21 to 30 of 1539
Sort by
Date
Title
Apply sorting
Last updated date between: 1/7/2016 and 1/12/2024
Remove Last updated date between: 1/7/2016 and 1/12/2024 filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Trifluridine–tipiracil with bevacizumab for treating metastatic colorectal cancer after 2 systemic treatments
TA1008
25 September 2024
25 September 2024
Burosumab for treating X-linked hypophosphataemia in children and young people
HST8
10 October 2018
20 September 2024
Rucaparib for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer
TA1007
17 September 2024
17 September 2024
Empagliflozin for treating type 2 diabetes in people 10 to 17 years (terminated appraisal)
TA1006
12 September 2024
12 September 2024
Evinacumab for treating homozygous familial hypercholesterolaemia in people 12 years and over
TA1002
11 September 2024
11 September 2024
Exagamglogene autotemcel for treating transfusion-dependent beta-thalassaemia in people 12 years and over
TA1003
11 September 2024
11 September 2024
Faricimab for treating visual impairment caused by macular oedema after retinal vein occlusion
TA1004
11 September 2024
11 September 2024
Futibatinib for previously treated advanced cholangiocarcinoma with FGFR2 fusion or rearrangement
TA1005
11 September 2024
11 September 2024
Iptacopan for treating paroxysmal nocturnal haemoglobinuria
TA1000
4 September 2024
4 September 2024
Zanubrutinib for treating marginal zone lymphoma after anti-CD20-based treatment
TA1001
4 September 2024
4 September 2024
Previous page
1
2
Current page
3
4
5
…
154
Page
3
of
154
Next page
Results per page
10
25
50
All
Back to top